This site is intended for healthcare professionals
Glaucoma Learning Zone
Declaration of sponsorship Novartis Pharma AG

Publication digests

Declaration of sponsorship Novartis Pharma AG
Read time: 15 mins
Last updated:9th Jun 2022
Published:9th Jun 2022

The Publication Digests section of this Learning Zone provides simplified detail and graphical summaries of the latest published research on glaucoma treatments.

The peer-reviewed article in this section describes:

  • a phase 4 double-blind trial to evaluate the effect of brinzolamide 1%/brimonidine 2% fixed-dose combination as an adjunct to a prostaglandin analogue in patients with open angle glaucoma or ocular hypertension

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension

The trial showed that twice daily administration of brinzolamide/brimonidine fixed-dose combination in addition to a prostaglandin analogue (PGA) resulted in a significantly greater reduction in mean diurnal intraocular pressure than PGA monotherapy in patients with open-angle glaucoma or ocular hypertension.

Download publication digest